July 3, 2026/
The phrase “patient capital” gets used a lot in venture circles. Usually it’s positioning — a fund saying it won’t pressure founders to exit on...
Investing with Evolve Venture Capital gives you access to well-researched startup portfolio investment opportunities — combining strong financial returns with measurable social impact across Singapore and Southeast Asia.
Only the most promising businesses make it to our portfolio.
Rely on our comprehensive due diligence.
Partner with businesses that make a difference while delivering returns.
Capital for pre-seed and seed-stage startups building their first product and initial customer base.
Expansion funding for startups with proven traction scaling operations across Singapore and Southeast Asia.
Impact-driven capital for companies building climate, health, and social solutions in the region.
Supporting deep-tech founders in AI, biotech, and advanced manufacturing across Singapore and Asia.
Every startup portfolio investment is thoroughly screened using data-driven analysis and experienced local counsel — reducing risk while maximising long-term financial returns and sustainable growth across the Singapore market.
Every Singapore venture capital investment option is put through a rigorous, multi-stage vetting process.
Reduce uncertainty in your startup portfolio with our proprietary analytical tools and Singapore market insights.
Receive guidance from Singapore-based VC experts dedicated to optimising your co-invest venture capital decisions.
Find co-invest venture capital opportunities in Singapore that redefine what success looks like.
Investing with Evolve means joining a Singapore-based venture capital community united by innovation, integrity, and impact — whether you are entering from angel stage or scaling to institutional VC.
The phrase “patient capital” gets used a lot in venture circles. Usually it’s positioning — a fund saying it won’t pressure founders to exit on...
Getting to a term sheet is hard. Getting through due diligence is where most deals die — not because founders can’t answer the questions, but...
There’s a quiet reallocation happening in Southeast Asian venture capital right now, and most founders and fund watchers are missing it because they’re looking at...
